文献速递睡眠呼吸障碍

通气负荷作为阻塞性睡眠呼吸暂停严重程度指标可预测心血管及全因死亡

Ventilatory Burden as a Measure of Obstructive Sleep Apnea Severity Is Predictive of Cardiovascular and All-Cause Mortality.
PubMed 文献 · Am J Respir Crit Care Med · 2023-01-01

本研究提出一种自动测量的新指标「通气负荷」(VB),定义为夜间呼吸中归一化幅度低于50%的呼吸比例。利用两个流行病学队列和两个临床队列,研究者建立了VB的正常范围,发现VB与上气道阻塞程度呈剂量反应关系,且夜间变异性低。在SHHS队列中,VB可预测全因和心血管疾病死亡,而AHI仅预测全因死亡,提示VB可能替代AHI评估OSA严重程度。

要点

  • VB是夜间呼吸中幅度低于50%的呼吸比例,自动测量且夜间变异性低。
  • VB与上气道阻塞程度呈剂量反应关系,可区分未治疗、治疗不充分和有效治疗。
  • VB可预测全因和心血管疾病死亡,而AHI仅预测全因死亡。

核心结论

  • 自动测量的通气负荷(VB)能有效评估阻塞性睡眠呼吸暂停严重程度,并可预测全因和心血管疾病死亡,可能成为AHI的可行替代指标。

研究设计与样本

  • 研究使用两个流行病学队列(EPISONO和SHHS)和两个回顾性临床队列(DAYFUN和纽约大学脑健康中心)的数据。
  • 研究目的包括:推导VB的正常范围、评估上气道阻塞程度与VB的关系、以及VB与全因和心血管疾病死亡的关系(调整或不调整缺氧负荷)。

主要发现

  • 在EPISONO和DAYFUN队列的无症状健康受试者中,VB的第95百分位数分别为25.2%和26.7%(中位数[四分位距]:EPISONO 5.5[3.5-9.7]%;DAYFUN 9.8[6.4-15.6]%)。
  • VB与上气道阻塞程度呈剂量反应关系:未治疗组31.6[27.1]%,治疗组7.2[4.7]%,治疗不充分组17.6[18.7]%,停止治疗组41.6[18.1]%。
  • VB的夜间变异性低(组内相关系数[2,1]为0.89)。
  • 在SHHS队列中,VB在调整包括缺氧负荷在内的协变量前后均可预测全因和心血管疾病死亡。
  • 在SHHS队列中,AHI可预测全因死亡,但与心血管疾病死亡无关。

关键数值与推荐

  • 无症状健康受试者VB的第95百分位数:EPISONO队列25.2%,DAYFUN队列26.7%。
  • VB中位数(四分位距):EPISONO队列5.5(3.5-9.7)%,DAYFUN队列9.8(6.4-15.6)%。
  • 不同治疗状态下VB值:未治疗31.6(27.1)%,治疗7.2(4.7)%,治疗不充分17.6(18.7)%,停止治疗41.6(18.1)%。
  • VB的组内相关系数(2,1)为0.89。

临床怎么用

  • VB可作为评估OSA严重程度的自动化指标,辅助识别心血管疾病死亡风险较高的患者。
  • VB可能用于监测治疗效果,区分治疗充分与否。
  • 在临床研究中,VB有望替代AHI作为OSA严重程度的终点指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: The apnea-hypopnea index (AHI), used for the diagnosis of obstructive sleep apnea, captures only the frequency of respiratory events and has demonstrable limitations. Objectives: We propose a novel automated measure, termed "ventilatory burden" (VB), that represents the proportion of overnight breaths with less than 50% normalized amplitude, and we show its ability to overcome limitations of AHI. Methods: Data from two epidemiological cohorts (EPISONO [Sao Paolo Epidemiological Study] and SHHS [Sleep Heart Health Study]) and two retrospective clinical cohorts (DAYFUN; New York University Center for Brain Health) were used in this study to 1) derive the normative range of VB, 2) assess the relationship between degree of upper airway obstruction and VB, and 3) assess the relationship between VB and all-cause and cardiovascular disease (CVD) mortality with and without hypoxic burden that was derived using an in-house automated algorithm. Measurements and Main Results: The 95th percentiles of VB in asymptomatic healthy subjects across the EPISONO and the DAYFUN cohorts were 25.2% and 26.7%, respectively (median [interquartile range], VBEPISONO, 5.5 [3.5-9.7]%; VBDAYFUN, 9.8 [6.4-15.6]%). VB was associated with the degree of upper airway obstruction in a dose-response manner (VBuntreated, 31.6 [27.1]%; VBtreated, 7.2 [4.7]%; VBsuboptimally treated, 17.6 [18.7]%; VBoff-treatment, 41.6 [18.1]%) and exhibited low night-to-night variability (intraclass correlation coefficient [2,1], 0.89). VB was predictive of all-cause and CVD mortality in the SHHS cohort before and after adjusting for covariates including hypoxic burden. Although AHI was predictive of all-cause mortality, it was not associated with CVD mortality in the SHHS cohort. Conclusions: Automated VB can effectively assess obstructive sleep apnea severity, is predictive of all-cause and CVD mortality, and may be a viable alternative to the AHI.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Parekh A, Kam K, Wickramaratne S, et al. Ventilatory Burden as a Measure of Obstructive Sleep Apnea Severity Is Predictive of Cardiovascular and All-Cause Mortality. Am J Respir Crit Care Med. 2023. PMID: 37698405. doi:10.1164/rccm.202301-0109OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。